Optimistic Investors Push Synthaverse S.A. (WSE:SVE) Shares Up 26% But Growth Is Lacking
May 20
Have your own idea? Try our Stock Screener
Polish (WIG) Biotech Industry Analysis
UpdatedJul 08, 2025
DataAggregated Company Financials
Companies12
- 7D-0.003%
- 3M3.5%
- 1Y-12.6%
- YTDn/a
Over the last 7 days, the Biotech industry has remained flat, although notably Captor Therapeutics Spolka Akcyjna gained 6.8%. As for the longer term, the industry has declined 11% in the last year. Looking forward, earnings are forecast to grow by 47% annually.
Industry Valuation and Performance
Has the Polish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 08 Jul 2025 | zł2.0b | zł401.8m | -zł140,766,468.00 | 32.1x | -14.4x | 5x |
| Thu, 05 Jun 2025 | zł2.0b | zł398.3m | -zł143,191,028.00 | 47.9x | -14.2x | 5.1x |
| Sat, 03 May 2025 | zł2.1b | zł396.8m | -zł112,335,193.00 | 51.2x | -18.7x | 5.3x |
| Mon, 31 Mar 2025 | zł2.0b | zł438.8m | -zł95,426,193.00 | 31x | -20.8x | 4.5x |
| Wed, 26 Feb 2025 | zł2.0b | zł438.6m | -zł94,885,631.00 | 29.8x | -21.3x | 4.6x |
| Fri, 24 Jan 2025 | zł1.9b | zł408.7m | -zł84,434,269.00 | 42.2x | -22.8x | 4.7x |
| Sun, 22 Dec 2024 | zł1.8b | zł408.7m | -zł84,434,269.00 | 37.7x | -21.5x | 4.5x |
| Tue, 19 Nov 2024 | zł1.9b | zł401.6m | -zł85,417,969.00 | 60.2x | -22.6x | 4.8x |
| Thu, 17 Oct 2024 | zł2.2b | zł438.7m | -zł64,845,969.00 | 62.4x | -33.5x | 5x |
| Sat, 14 Sep 2024 | zł2.1b | zł442.8m | -zł53,453,784.00 | 62.8x | -39.8x | 4.8x |
| Mon, 12 Aug 2024 | zł2.2b | zł444.2m | -zł64,230,755.00 | 73.5x | -33.6x | 4.9x |
| Wed, 10 Jul 2024 | zł2.1b | zł444.2m | -zł64,230,755.00 | 71x | -33.1x | 4.8x |
| Fri, 07 Jun 2024 | zł2.0b | zł439.7m | -zł90,277,755.00 | 71x | -22.5x | 4.6x |
| Sun, 05 May 2024 | zł2.3b | zł441.3m | -zł90,006,665.00 | 55.6x | -25.2x | 5.1x |
| Tue, 02 Apr 2024 | zł2.2b | zł432.0m | -zł73,964,007.00 | 59.6x | -29.3x | 5x |
| Thu, 29 Feb 2024 | zł2.3b | zł462.1m | -zł74,341,007.00 | 58.7x | -31.4x | 5.1x |
| Sat, 27 Jan 2024 | zł2.7b | zł499.9m | -zł66,755,911.00 | 88.6x | -40.7x | 5.4x |
| Mon, 25 Dec 2023 | zł2.7b | zł499.9m | -zł66,755,911.00 | 89.5x | -40x | 5.3x |
| Wed, 22 Nov 2023 | zł2.6b | zł503.4m | -zł49,524,983.00 | 45.9x | -51.6x | 5.1x |
| Fri, 20 Oct 2023 | zł2.7b | zł518.4m | -zł60,859,678.00 | 48.7x | -44.3x | 5.2x |
| Sun, 17 Sep 2023 | zł2.9b | zł514.2m | -zł59,940,668.00 | 50.5x | -47.6x | 5.6x |
| Tue, 15 Aug 2023 | zł2.9b | zł520.1m | -zł43,410,661.00 | 51.6x | -66.2x | 5.5x |
| Thu, 13 Jul 2023 | zł2.9b | zł520.7m | -zł42,515,291.00 | 53.8x | -67.6x | 5.5x |
| Sat, 10 Jun 2023 | zł2.9b | zł517.3m | -zł42,548,721.00 | 63.5x | -67.4x | 5.5x |
| Mon, 08 May 2023 | zł2.9b | zł520.8m | -zł38,826,826.00 | 66x | -75.8x | 5.7x |
| Wed, 05 Apr 2023 | zł2.8b | zł488.3m | -zł16,018,449.00 | 59.1x | -176.3x | 5.8x |
| Fri, 03 Mar 2023 | zł2.9b | zł488.6m | -zł16,165,349.00 | 67.8x | -179x | 5.9x |
| Sun, 29 Jan 2023 | zł3.0b | zł496.5m | -zł10,783,764.00 | 47.7x | -277.5x | 6x |
| Tue, 27 Dec 2022 | zł2.6b | zł496.5m | -zł10,783,764.00 | 45.1x | -245.6x | 5.3x |
| Thu, 24 Nov 2022 | zł2.8b | zł460.7m | -zł18,977,067.00 | 50.8x | -146.2x | 6x |
| Sat, 22 Oct 2022 | zł2.6b | zł444.0m | -zł13,473,868.00 | 56.6x | -192.4x | 5.8x |
| Mon, 19 Sep 2022 | zł2.7b | zł407.9m | -zł21,088,868.00 | 58.8x | -129.5x | 6.7x |
| Wed, 17 Aug 2022 | zł2.8b | zł389.5m | -zł7,000,909.00 | 63.6x | -393.8x | 7.1x |
| Fri, 15 Jul 2022 | zł2.4b | zł472.9m | zł66,686.00 | 26.5x | 35678.9x | 5x |
Price to Earnings Ratio
35678.9x
Current Industry PE
- Investors are relatively neutral on the Polish Biotechnology industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 5.3x.
Past Earnings Growth
- Total earnings for the Biotechnology industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 5.3% per year, which is driving profits down.
Industry Comparison
How does Polish Biotech compare with similar industries?
| PL Market | 0.60% | |
| Healthcare | -0.16% | |
| Biotech | -0.0028% | |
| Biotech | -0.0028% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CTX Captor Therapeutics Spolka Akcyjna | zł37.00 | 9.8% +zł18.2m | -50.3% | PS14.7x | |
| PTG Poltreg | zł33.00 | 5.1% +zł7.5m | -34.3% | PS615.6x | |
| BIO BIOTON | zł4.16 | 2.0% +zł6.9m | 22.4% | PS1.5x | |
| GMT Genomtec | zł7.00 | 3.7% +zł3.7m | -33.1% | PS17345x | |
| MAB Mabion | zł10.00 | 1.1% +zł1.8m | -42.3% | PS4.3x |